Clinical Trial Update: Named Patient Program for Mitomycin for Pyelocalyceal Solution

View source ↗

Summary

This clinical-trials.gov update describes a named patient program for mitomycin-C delivered as a pyelocalyceal solution to treat urothelial carcinoma in the ren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma
• Urothelial Carcinoma Recurrent
• Urothelial Carcinoma of the Renal Pelvis
• Urothelial Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter | Status: AVAILABLE